• Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access

• Cheng Zhang

• Wang Feng, Liu Jianfei

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 417 ~ 419

• Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis agg...

• Phowthongkum Prasit

• Suphapeetiporn Kanya, Shotelersuk Vorasuk

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 412 ~ 416

• Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus ...

• Khayat Ammar Abdulaziz

• Telega Grzegorz W.

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 408 ~ 411

• An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b...

• Lee Youn-Jae

• Heo Jeong, Kim Do-Young, Chung Woo-Jin, Tak Won-Young, Kim Yoon-Jun, Paik Seung-Woon, Sim ...

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 400 ~ 407

• Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patient...

• Shin Haneulsaem

• Jung Yeon-Woo, Kim Beom-Kyung, Park Jun-Yong, Kim Do-Young, Ahn Sang-Hoon, Han Kwang-Hyub, ...

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 390 ~ 399

• Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular ca...

• Moriya Kei

• Namisaki Tadashi, Sato Shinya, Furukawa Masanori, Douhara Akitoshi, Kawaratani Hideto, Kaji Kos...

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 381 ~ 389

• Incidence and risk factors of dysphagia after variceal band ligation

• Arasu Saraswathi

• Liaquat Hammad, Ehrlich Adam C., Friedenberg Frank K.

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 374 ~ 380

• Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemother...

• Laiwatthanapaisan Ratchapong

• Sripongpun Pimsiri, Chamroonkul Naichaya, Dechaphunkul Arunee, Sathitruangsak Chirawadee, Sakdejayon...

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 366 ~ 373

• Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure

• Parigi Tommaso Lorenzo

• Torres Maria Corina Plaz, Aghemo Alessio

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 360 ~ 365

• Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation ...

• Ahn Keun-Soo

• Kang Koo-Jeong

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 354 ~ 359

• Ultraselective conventional transarterial chemoembolization: When and how?

• Miyayama Shiro

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 344 ~ 353

• Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

• Yang Ju-Dong

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 335 ~ 343

• A leap for the journal: Clinical and Molecular Hepatology enters a new era

• Kim Yoon-Jun

• Clinical and Molecular Hepatology   2019  Volume.25  No.4 333 ~ 334

• Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardio...

• Patoulias Dimitrios

• Imprialos Konstantinos, Stavropoulos Konstantinos, Doumas Michael

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 331 ~ 332

• Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and s...

• Kumar Rahul

• Hsiang John Chen, Tan Jessica, Thurairajah Prem Harichander

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 326 ~ 330

• Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compen...

• Hassan Elham Ahmed

• El-Din Abdel Rehim Abeer Sharaf, Abdel-Malek Mohamed Omar, Ahmed Asmaa Omar, Abbas Nourhan Mahmoud

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 317 ~ 325

• Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lym...

• Wong Linda

• Bozhilov Kliment, Hernandez Brenda Y., Kwee Sandi, Chan Owen, Ellis Luke, Le Marchand Loic

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 305 ~ 316

• Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with...

• Banitalebi Ebrahim

• Faramarzi Mohammad, Nasiri Samira, Mardaniyan Majid, Rabiee Vahid

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 294 ~ 304

• Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with ent...

• Kim David Soo-Ik

• Jeon Mi-Young, Lee Hye-Won, Kim Beom-Kyung, Park Jun-Yong, Kim Do-Young, Ahn Sang-Hoon, Ha...

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 283 ~ 293

• How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

• Yu Jung-Hwan

• Lee Jin-Woo

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 280 ~ 282